Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on April 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NORETHINDRONE AND E

Closed
SPE2DP-26-T-3017Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract pertains to the procurement of Norethindrone and Ethinyl Estradiol Tablets, USP, a hormonal contraceptive product regulated by the FDA, manufactured by TEVA PHARMACEUTICALS USA, INC. Each package unit consists of six 28-tablet cycles, totaling 168 tablets per package, with each cycle including seven tablets of varying dosages—0.5 mg and 35 mcg, 0.75 mg and 35 mcg, and 1 mg and 25 mcg of active ingredients—plus seven inert tablets. The product must have a minimum shelf life of 36 months from manufacture and must not have more than five months elapsed between manufacture and delivery to the government, ensuring at least 31 months of remaining shelf life upon arrival. Packaging and labeling are strictly mandated to comply with Medical Marking Standard No. 1, superseding all prior standards including MIL-STD-129, and must be sealed within commercial containers designed to prevent damage during transit. Shipments must be properly marked, packed according to MIL-STD-2073-1E, and delivered FOB destination with zero tolerance for quantity variance. Storage conditions require a controlled room temperature of 25°C (77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The contract specifies three packages to be delivered within five days to APO 09126-3865 under solicitation SPE2DP-26-T-3017, with acceptance and inspection occurring at the destination point. The product is identified by NSN 6505-01-506-2659 and NDC 00555-9012-58, with procurement governed by DLA’s Master List of Technical and Quality Requirements and subject to covered defense information protocols.

General Info

Procurement of 168-tablet contraceptive packs, 36-month shelf life, FOB destination, compliant packaging, delivery to APO 09126-3865.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 3865 BOX, APO, AE, 09126-3865, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3017.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
NORETHINDRONE AND E
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
7 TABLETS WITH 0.5 MG & 35 MCG; 7 TABLETS WITH 0.75 MG & 35 MCG AND 7
TABLETS WITH 1 MG AND 25 MCG OF ACTIVE INGREDIENT PLUS 7 INERT TABLETS
28 TABLETS PER CYCLE, 6 CYCLES PER PKG UNIT OF ISSUE "PACKAGE" (6
CYCLES OF 28 TABLETS) SHALL HAVE A SHELF LIFE OF 36 MONTHS. NOT LESS
THAN 31 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. STORE AT
25°C (77°F); EXCURSIONS PERMITTED TO 15°#30°C (59°#86°F)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 PG = 168 TT
1 PG = 168 TT
This device or drug is regulated by the FDA.
SPE2DP-26-T-3017
SECTION B
Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-9012-58
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015321235 0001 PG 3.000
NSN/MATERIAL:6505015062659
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-506-2659 Quantity: 3 PG Purchase Request: 7016453663QTY: 4 Delivery: 5 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS